PATH Stock Plunges After Earnings As Traders Weigh BofA Call

UiPath Inc. stocks have been trading down by -7.18 percent amid bearish sentiment over automation demand and growth prospects.

Live Update At 12:32:38 EDT: On Tuesday, September 08, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -7.18%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath, trading under ticker PATH, is acting like a textbook post-earnings fade. Just days ago, PATH closed at 18.67 and held near the high teens for several sessions. After the new quarterly numbers and weak reaction, the stock has slid to 14.09, wiping out weeks of steady grinding gains. That’s a drop of roughly 25% from the late-August high, a key red flag for swing traders who rode the prior uptrend.

The daily chart shows PATH breaking down from the 18–19 range to the mid-teens in one shot, then failing to bounce meaningfully. On the most recent day, PATH opened at 15.16 and sold off to a 13.85 low before finishing near the lows at 14.09. That type of intraday action tells you dip buyers were weak and shorts stayed in control.

Zooming in, the 5‑minute chart is basically a slow bleed. PATH tried to stabilize around 14, but every small pop was sold. For active traders, that intraday pattern — lower highs, heavy supply, tight range — often signals continued caution until real volume shows up on the bid.

Fundamentally, PATH is not a broken business. Revenue is about $1.61B annually, with a very strong 83% gross margin. The latest quarter showed $418.4M in revenue and positive net income of $22.5M, plus about $129.2M in free cash flow. PATH carries very little debt, with total debt to equity near 0.04 and a current ratio of 2.3, so the balance sheet is clean. But at a price-to-sales ratio around 4.7 and a P/E near 25, traders are clearly questioning whether that growth multiple is still justified after the disappointing quarter and reaction.

Why Traders Are Watching PATH After The Selloff

PATH is now a battleground stock. The headline move is brutal: multiple reports confirm UiPath shares fell roughly 16%–17% after the latest quarterly earnings, on top of an 11% drop in early trading right after the release. When you see that kind of gap down plus follow‑through selling, you know big funds were not happy with what UiPath delivered or guided.

The interesting twist is the Wall Street backdrop. Bank of America raised its Pdth price target from $13 to $15, but still labels PATH as Underperform. That’s a rare combo — a higher target, yet still a bearish stance. The key reason: mixed fiscal Q2 results and doubt that UiPath’s AI push will truly accelerate annual recurring revenue growth. BofA is giving PATH some credit for better margin assumptions, but refusing to buy into the hype that AI alone will fix the growth story.

For traders, that tension is the setup. On one side, PATH has strong gross margins, real free cash flow, and a fortress balance sheet. On the other, the market just told you loud and clear it is not convinced about the growth runway, especially in a crowded automation and AI space.

Layer on insider activity. CEO Daniel Dines sold about 1.4 million PATH shares for roughly $22.5M. That’s a big number, and in the shadow of a weak quarter it naturally feeds bearish sentiment. But he still holds around 26.5M Class A shares, so he remains heavily tied to UiPath’s future. Traders watching insider flow will treat this as a yellow flag, not an automatic red light.

In short, PATH is where emotion and numbers collide: sharp drawdown, skeptical analysts, yet still a financially solid business. That mix often breeds short‑term trading opportunity, but also traps for anyone who forgets to manage risk.

Conclusion

PATH’s latest quarter turned into a harsh reality check. The stock unwound from the high teens to near $14 after earnings, with multiple reports confirming a 16%–17% post‑print slide. BofA’s decision to lift its price target to $15 while maintaining an Underperform rating underlines the message: UiPath is not collapsing, but Wall Street is far from convinced the AI story will translate into faster ARR growth.

Under the hood, PATH still boasts fat gross margins, positive earnings, and solid free cash flow. The balance sheet has plenty of cash and minimal debt. That’s why some longer‑term bulls will keep UiPath on their radar despite the drawdown. At the same time, the CEO’s 1.4 million‑share sale, even with his large remaining stake, adds more drama to a chart already broken in the near term.

For traders, this is exactly the kind of name that demands discipline. Volatility is high, emotions are higher, and the crowd is split. As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.”. As Tim Sykes loves to remind his students, “The market doesn’t care about your opinion — it rewards preparation and punishes stubbornness.” PATH is now a live case study in that rule. Study the chart, respect the levels, and, above all, cut losses quickly. This coverage is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks